{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-22-000108","form_type":"8-K/A","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2022-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.237980+00:00","generated_at":"2026-06-22T19:05:51.594736+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Nautilus appoints Karen Akinsanya to Nominating and Governance Committee","bullets":["Appointment effective October 27, 2022; committee now includes McIlwain (Chair), Pande, and Akinsanya.","Akinsanya joined the Board in March 2022; committee assignment was previously undetermined.","This amendment updates the original 8-K filed March 31, 2022 regarding Akinsanya's directorship."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-22-000108","json":"https://secwatch.observer/filing/0001808805-22-000108.json","markdown":"https://secwatch.observer/filing/0001808805-22-000108.md","text":"https://secwatch.observer/filing/0001808805-22-000108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000108/0001808805-22-000108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000108/naut-20220330.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T19:05:51.594736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}